AusPAR: Emtricitabine / rilpivirine / tenofovir alafenamide fumarate

Australian Public Assessment Report

AusPAR

AusPAR: Emtricitabine / rilpivirine / tenofovir alafenamide fumarate [PDF, 599.38 KB]

AusPAR: Emtricitabine / rilpivirine / tenofovir alafenamide fumarate [Word, 828.65 KB]

Attachment: Product Information: Emtricitabine / rilpivirine / tenofovir alafenamide fumarate [PDF, 489.93 KB]

Attachment: Product Information: Emtricitabine / rilpivirine / tenofovir alafenamide fumarate [Word, 204.17 KB]

Attachment: Extract from Clinical Evaluation Report: Emtricitabine / rilpivirine / tenofovir alafenamide fumarate [PDF, 885.99 KB]

Attachment: Extract from Clinical Evaluation Report: Emtricitabine / rilpivirine / tenofovir alafenamide fumarate [Word, 1.25 MB]

Device/Product Name

Odefsey

Active ingredients

Emtricitabine / rilpivirine / tenofovir alafenamide fumarate

AusPAR Date

12 October 2017

Published

2 November 2017

Submission Number

PM-2015-02479-1-2

Submission Type

New fixed dose combination

Decision

Approved